Left Ventricular Diastolic Dysfunction in β-Thalassemia Major with Heart Failure

Heart Failure With Preserved Ejection Fraction

(2016) Yogesh N.V. Reddy et al.   CURRENT PROBLEMS IN CARDIOLOGY

2016 ACC/AHA/HFSA Focused Update on New Pharmacological Therapy for Heart Failure: An Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure

(2016) Clyde W. Yancy et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Heart Failure with Preserved Ejection Fraction

(2016) Margaret M. Redfield   NEW ENGLAND JOURNAL OF MEDICINE

Myocardial fibrosis by late gadolinium enhancement cardiac magnetic resonance and hepatitis C virus infection in thalassemia major patients

(2015) Alessia Pepe et al.   Journal of Cardiovascular Medicine

Heart Failure with Preserved Ejection Fraction: Current Understandings and Challenges

(2014) Mads J. Andersen et al.   Current Cardiology Reports

Serial echocardiographic left ventricular ejection fraction measurements: A tool for detecting thalassemia major patients at risk of cardiac death

(2013) Aurelio Maggio et al.   BLOOD CELLS MOLECULES AND DISEASES

Cardiovascular Function and Treatment in β-Thalassemia Major

(2013) Dudley J. Pennell et al.   CIRCULATION

Trends in Patients Hospitalized With Heart Failure and Preserved Left Ventricular Ejection Fraction

(2012) Benjamin A. Steinberg et al.   CIRCULATION

Utility of Combined Indexes of Electrocardiography and Echocardiography in the Diagnosis of Biopsy Proven Primary Cardiac Amyloidosis

(2011) Zhongwei Cheng et al.   ANNALS OF NONINVASIVE ELECTROCARDIOLOGY

Clinical management of cardiovascular complications in patients with thalassaemia major: a large observational multicenter study

(2011) G. Derchi et al.   European Journal of Echocardiography

Heart failure with preserved ejection fraction: pathophysiology, diagnosis, and treatment

(2010) B. A. Borlaug et al.   EUROPEAN HEART JOURNAL

Guideline recommendations for heart complications in thalassemia major

(2010) Tiziana Cogliandro et al.   Journal of Cardiovascular Medicine

Myocardial T2* is not affected by ageing, myocardial fibrosis, or impaired left ventricular function

(2010) Paul Kirk et al.   JOURNAL OF MAGNETIC RESONANCE IMAGING

Cardiac mortality in β-thalassemia major: resting but not dobutamine stress echocardiography predicts mortality among initially cardiac disease-free patients in a prospective 12-year study

(2009) George Hahalis et al.   EUROPEAN JOURNAL OF HEART FAILURE

Myocardial scarring by delayed enhancement cardiovascular magnetic resonance in thalassaemia major

(2009) A Pepe et al.   HEART